The chemotherapy-induced myelosuppression treatments market share is expected to increase from its present size of US$ 8.06 billion in 2022 to US$ 9.78 billion by 2028, with a cumulative annual growth rate (CAGR) of 3.3%. The Chemotherapy-Induced Treatment Market plays a vital role in the comprehensive care of cancer patients, addressing the often debilitating side …